has received another COVID-19 vaccine has ever fainted in association with an injection.The safety and effectiveness of the Moderna COVID-19 Vaccine 2024-2025 Formula has not been evaluated in children less than 12 years of age, but data is available for previous vaccine formulations that were...
Gam-COVID-Vac, trade-named Sputnik V, is a COVID-19 vaccine developed by the Gamaleya National Center of Epidemiology and Microbiology of Moscow, Russia. Sputnik V is a two-vector viral vaccine based on human adenoviruses. Sputnik V uses adenoviruses Ad5 and Ad2618. The recombinant adenovirus...
Cov19VaxKB features comprehensive lists of COVID-19 vaccines, vaccine formulations, clinical trials, publications, news articles, and vaccine adverse event case reports. A web-based query interface enables comparison of product information and host responses among various vaccines. The knowledge base ...
Indeed, decisions faced by pregnant individuals during the pandemic were particularly complex, with a need to balance benefits and risks of novel vaccine formulations, which may have differentially impacted mother and fetus. In this prospective cohort study, we observed no difference in risk of ...
The HHS COVID-19 Community Corps will reach parents and families about vaccinations for kids under the age of five. Launched last April to empower people and organizations to build vaccine confidence in their communities, the Community Corps now has over 17,000 members, including health care, fa...
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study. Lancet Infect Dis. 2021;21(9):1257-1270. doi:10.1016/S1473-3099(21)00147-X PubMedGoogle ScholarCross...
Individuals 6 months through 4 years of age who have previously been vaccinated against COVID-19 are eligible to receive one or two doses of an updated mRNA COVID-19 vaccine (timing and number of doses to administer depends on the previous COVID-19 ...
There are 2 formulations of Pfizer-BioNTech COVID-19 Vaccine authorized for use in individuals 12 years of age and older: The formulation supplied in a multiple dose vial with a purple cap MUST BE DILUTED PRIOR TO USE. The formulation supplied in a multiple dose vial with a gray cap an...
Y. et al. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. Lancet 396, 887–897 (2020). Article CAS Google Scholar Voysey, M. et al. Safety and efficacy...
https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-49-omicron/ 9. UK Health Security Agency. COVID-19 vaccine surveillance report: week 3. January 20, 2022. Accessed January 21, 2022. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/...